Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
US 6,713,072 Lapsed on the fee recordLapsed Mar 30, 2016 on the fee record · From the USPTO record
20-year base term ended Mar 30, 2021
Third maintenance fee unpaid; grace period ended.
Nov 1, 1988
Mar 30, 2016
Mar 30, 2004
Nov 2, 2021
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, the 1995 transition rule | Granted Mar 30, 2004 + 17 years, or clock starts Nov 1, 1988 + 20 years, whichever is later; a parent in its chain could not be resolved (the next row) | Mar 30, 2021 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +217 days, USPTO patent term adjustment record | Nov 2, 2021 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Mar 30, 2016 | High confidence |
| Computed term end | The steps above, in order | Mar 30, 2016 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.